Efficacy of Oral Apremilast in the Treatment of Alopecia Areata at the Tertiary Care Hospital, Karachi.
Condition: Alopecia Areata Intervention: Drug: Apremilast 30mg Sponsor: Jinnah Postgraduate Medical Centre Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)
Condition: Alopecia, Androgenetic Interventions: Drug: Clascoterone 5% solution; Drug: Vehicle solution Sponsors: Cassiopea SpA; Ergomed PLC; Pharmapace Inc; Canfield Scientific Inc.; ICON Clinical Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials